Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
StageZero Life Sciences Ltd
T.SZLS
Alternate Symbol(s):
SZLSF
Healthcare
Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease...
(AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SZLS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(7)
•••
Directvoice
X
View Profile
View Bullboard History
Post by
Directvoice
on Mar 14, 2024 1:25pm
In the good direction
In good direction to be the worst stock for investors I think this stock needs to pivot to a different business direction in the oncology sector . With RNA cancer vacine that will soon be
...more
(289)
•••
IainCaimbeul
X
View Profile
View Bullboard History
Post by
IainCaimbeul
on Mar 13, 2024 12:39pm
Just watched a Video from 2014/2015,
where Tripp announces that ColonSentry is now our flagship product. Indeed, then show us the sales numbers. Has ColonSentry been supplanted by the newest flagship product Aristotle. Again, shows us
...more
(289)
•••
IainCaimbeul
X
View Profile
View Bullboard History
Comment by
IainCaimbeul
on Mar 13, 2024 12:32pm
RE:RE:Reserve a call.
I do believe other folks on this board will see you have no rebuttal, but resort to childish cartoon antics. The real nailbiter1/2 always shows up , he just cannot help himself.
(289)
•••
IainCaimbeul
X
View Profile
View Bullboard History
Post by
IainCaimbeul
on Mar 12, 2024 2:39pm
Reserve a call.
Guess that has gone the way of Oncore. The Oncore "agreement" NR from 10 Oct 2019. Just wondering if the revenue cheques are rolling in yet? Just setting the stage for 1 April 2024 YE
...more
(289)
•••
IainCaimbeul
X
View Profile
View Bullboard History
Post by
IainCaimbeul
on Mar 12, 2024 12:54pm
Daily Laugh ...
Some of the doozie commments (maybe by Rebecca) from the latest video entitled: Diving Into What to Expect from the Company in 2024 "James, I like your channel very much. It's so
...more
(20)
•••
stanem1
X
View Profile
View Bullboard History
Post by
stanem1
on Mar 12, 2024 11:45am
Need money for clinic
A cancer clinic requires equipment, all the money has been spent on nose candy
(30)
•••
4real4ever
X
View Profile
View Bullboard History
Comment by
4real4ever
on Mar 11, 2024 5:15pm
RE:FAQ doc SZLS, June 2021
LMAO Everyboby knows NOW
(289)
•••
IainCaimbeul
X
View Profile
View Bullboard History
Post by
IainCaimbeul
on Mar 11, 2024 12:51pm
FAQ doc SZLS, June 2021
1. Preparation for potential US listing: the Corporation is looking to prepare for a possible future listing on NASDAQ or other senior US stock exchange. The higher anticipated price of the post
...more
(289)
•••
IainCaimbeul
X
View Profile
View Bullboard History
Comment by
IainCaimbeul
on Mar 07, 2024 2:14pm
RE:Qualifications:
*Governor
(289)
•••
IainCaimbeul
X
View Profile
View Bullboard History
Post by
IainCaimbeul
on Mar 07, 2024 1:39pm
Qualifications:
Garth MacRae - CPA; Harry Glorikian - MBA; Rory Riggs - MBA; James Howard-Tripp - nothing. Tripp is unqualified and incapable to be the CEO of Stagezero, to him the company is just a giant ATM for
...more
(30)
•••
4real4ever
X
View Profile
View Bullboard History
Post by
4real4ever
on Mar 07, 2024 11:25am
Even pumpers
are gone
(30)
•••
4real4ever
X
View Profile
View Bullboard History
Post by
4real4ever
on Mar 06, 2024 10:05am
5 years later and
How did they survive without any income since 5 years Oh yeah PP and shareholders
(30)
•••
4real4ever
X
View Profile
View Bullboard History
Post by
4real4ever
on Mar 01, 2024 8:06pm
Well, well, well
Same share price Same lies Same loser pumpers
(21)
•••
molotov421
X
View Profile
View Bullboard History
Post by
molotov421
on Feb 29, 2024 2:08pm
Games
Saw bids at 4.5 earlier. 10 minutes later 140k asks at 4.5. no hope in sight around here. FML
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income